A comparative study of survival models for breast cancer prognostication revisited: the benefits of multi-gene models

BACKGROUND: The development of clinical -omic biomarkers for predicting patient prognosis has mostly focused on multi-gene models. However, several studies have described significant weaknesses of multi-gene biomarkers. Indeed, some high-profile reports have even indicated that multi-gene biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Grzadkowski, Michal R., Sendorek, Dorota H., P’ng, Christine, Huang, Vincent, Boutros, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215649/
https://www.ncbi.nlm.nih.gov/pubmed/30390622
http://dx.doi.org/10.1186/s12859-018-2430-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215649/
https://www.ncbi.nlm.nih.gov/pubmed/30390622
http://dx.doi.org/10.1186/s12859-018-2430-9

Ejemplares similares